ES533793A0 - Compuesto farmaceutico apropiado para administracion por via intestinal - Google Patents

Compuesto farmaceutico apropiado para administracion por via intestinal

Info

Publication number
ES533793A0
ES533793A0 ES533793A ES533793A ES533793A0 ES 533793 A0 ES533793 A0 ES 533793A0 ES 533793 A ES533793 A ES 533793A ES 533793 A ES533793 A ES 533793A ES 533793 A0 ES533793 A0 ES 533793A0
Authority
ES
Spain
Prior art keywords
pharmaceutical compound
compound suitable
intestinal administration
intestinal
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES533793A
Other languages
English (en)
Other versions
ES8605377A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Publication of ES8605377A1 publication Critical patent/ES8605377A1/es
Publication of ES533793A0 publication Critical patent/ES533793A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES533793A 1983-06-29 1984-06-28 Compuesto farmaceutico apropiado para administracion por via intestinal Expired ES8605377A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58116089A JPS608225A (ja) 1983-06-29 1983-06-29 腸管吸収医薬組成物

Publications (2)

Publication Number Publication Date
ES8605377A1 ES8605377A1 (es) 1986-04-01
ES533793A0 true ES533793A0 (es) 1986-04-01

Family

ID=14678433

Family Applications (1)

Application Number Title Priority Date Filing Date
ES533793A Expired ES8605377A1 (es) 1983-06-29 1984-06-28 Compuesto farmaceutico apropiado para administracion por via intestinal

Country Status (5)

Country Link
US (2) US4639435A (es)
EP (1) EP0130779A3 (es)
JP (1) JPS608225A (es)
CA (1) CA1209906A (es)
ES (1) ES8605377A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691181A (en) * 1984-08-21 1997-11-25 Celltech Limited DNA encoding lipase from human gastric mucosal tissue
JPS6164592U (es) * 1984-10-03 1986-05-01
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
US5338724A (en) * 1986-11-26 1994-08-16 Cornell Research Foundation, Inc. Antimicrobial proteins, compositions containing same and uses thereof
US4778821A (en) * 1987-07-15 1988-10-18 International Minerals & Chemical Corp. Method for controlling helmintic parasites
US5017560A (en) * 1987-11-06 1991-05-21 Pitman-Moore, Inc. Poultry growth promotion
US6153592A (en) * 1992-11-09 2000-11-28 Port Systems, Llc Enhancing the bioavailability of proteolytically labile therapeutic agents
US5873358A (en) * 1993-01-29 1999-02-23 Aradigm Corporation Method of maintaining a diabetic patient's blood glucose level in a desired range
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US5970973A (en) * 1993-01-29 1999-10-26 Aradigm Corporation Method of delivering insulin lispro
US5915378A (en) * 1993-01-29 1999-06-29 Aradigm Corporation Creating an aerosolized formulation of insulin
US5888477A (en) * 1993-01-29 1999-03-30 Aradigm Corporation Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
US5743250A (en) * 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
US6024090A (en) * 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
SE9300937L (sv) * 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
US5424289A (en) * 1993-07-30 1995-06-13 Alza Corporation Solid formulations of therapeutic proteins for gastrointestinal delivery
US5858398A (en) * 1994-11-03 1999-01-12 Isomed Inc. Microparticular pharmaceutical compositions
US5514825A (en) * 1994-12-29 1996-05-07 Allergan, Inc. Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
IL155136A0 (en) * 2003-02-10 2003-10-31 Enzymotec Ltd A composition for reducing blood cholesterol and triglycerides
US7459155B2 (en) * 2003-10-29 2008-12-02 Altus Pharmaceuticals Inc. Treating abdominal pain due to pancreatitis with seaprose
WO2005074575A2 (en) * 2004-01-30 2005-08-18 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
BRPI0514244A (pt) * 2004-08-09 2008-06-03 Enzymotec Ltd produtos alimentìcios para diabéticos
WO2006016363A2 (en) 2004-08-10 2006-02-16 Enzymotec Ltd. Mixture of phytosterol ester(s) and 1, 3-diglyceride(s) for use in the treatment of medical conditions
US20090317364A1 (en) * 2006-07-10 2009-12-24 Chandrakant Laxminarayan Rathi Novel compositions for prevention and treatment of mastitis and metritis
RU2491075C2 (ru) 2006-12-22 2013-08-27 Айронвуд Фармасьютикалз, Инк. Способы и композиции для лечения расстройств пищевода
US8709428B2 (en) 2009-02-20 2014-04-29 Health Protection Agency Antibodies to Clostridium difficile toxins
US9931381B2 (en) * 2009-11-23 2018-04-03 Prothera, Inc. Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
GB0921288D0 (en) 2009-12-04 2010-01-20 Health Prot Agency Therapies for preventing or suppressing clostridium difficile infection
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
AU2014207680B2 (en) 2013-01-15 2018-09-06 Ironwood Pharmaceuticals, Inc. Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57109192A (en) * 1980-12-24 1982-07-07 Toshiba Corp Charge coupling type quantizing device
JPS57109102A (en) * 1980-12-24 1982-07-07 Toshiba Corp Cassette tape recorder
JPS584686A (ja) * 1981-06-26 1983-01-11 Shigenobu Furukawa 多目的貨物船におけるコンテナ等積み付け方法
JPS5821622A (ja) * 1981-07-28 1983-02-08 Kowa Co 糖尿病治療用薬剤
EP0071433A1 (en) * 1981-07-28 1983-02-09 Kowa Company, Ltd. Medicine for the treatment of diabetes
JPS58225080A (ja) * 1982-06-25 1983-12-27 Kowa Co ベンゾイルピペラジン誘導体
AU545463B2 (en) * 1982-06-25 1985-07-18 Kowa Co. Ltd. Benzoyl piperacine esters

Also Published As

Publication number Publication date
EP0130779A2 (en) 1985-01-09
US4639435A (en) 1987-01-27
JPS608225A (ja) 1985-01-17
CA1209906A (en) 1986-08-19
EP0130779A3 (en) 1987-12-02
ES8605377A1 (es) 1986-04-01
US4755383A (en) 1988-07-05

Similar Documents

Publication Publication Date Title
ES533793A0 (es) Compuesto farmaceutico apropiado para administracion por via intestinal
DK163959C (da) Farmaceutisk praeparat til oral indgift indeholdende cimetidin
DK464383A (da) Medikamentadministreringsapparat
IT1169806B (it) Dispositivo per la somministrazione controllata di farmaci
EP0128831A3 (en) Drug administration
ES540177A0 (es) Sistema cerrado para administracion de medicinas
DK68392A (da) Farmaceutisk praeparat indeholdende cefuroximaxetil
MX9203263A (es) Composicion farmaceutica analgesica para administracion nasal.
DK89090D0 (da) Farmaceutisk praeparat
DK362189A (da) Farmaceutisk praeparat til intravenoes indgift
ES524892A0 (es) Un procedimiento para la preparacion de una tableta farmaceutica
AU2823284A (en) Apparatus for the oral administration of capsules to animals
DK705488A (da) Farmaceutisk praeparat
DK272383D0 (da) Farmaceutisk blandingspraeparat
DK79889A (da) Flerlagsplaster til transdermal laegemiddeladministration
DK158599C (da) Allergenpraeparat til oral administration
MX14533A (es) Procedimiento para la preparacion de compuestos farmaceuticos
DK559288D0 (da) Farmaceutisk praeparat for piperidinoalkanolderivater
IT8424159A0 (it) Composizioni farmaceutiche antitumorali e procedimento per laloro preparazione.
ES542846A0 (es) Procedimiento para producir un preparado farmaceutico desti-nado a aplicacion por via topica
DK139388A (da) Farmaceutisk praeparat
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
IT1191156B (it) Procedimento per preparare composti lassativi da droga di senna
DK37589A (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
IT8467927A0 (it) Preparati farmaceutici a base di dobutamina somministrabili per via orale

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203